These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24337682)

  • 1. Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo.
    Hu Y; Li S; Yang M; Yan C; Fan D; Zhou Y; Zhang Y; Yagüe E; Xiong D
    Breast Cancer Res Treat; 2014 Jan; 143(2):287-99. PubMed ID: 24337682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.
    Han M; Wang Y; Liu M; Bi X; Bao J; Zeng N; Zhu Z; Mo Z; Wu C; Chen X
    Cancer Sci; 2012 Jun; 103(6):1058-64. PubMed ID: 22435731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.
    Han M; Liu M; Wang Y; Mo Z; Bi X; Liu Z; Fan Y; Chen X; Wu C
    Mol Cell Biochem; 2012 Apr; 363(1-2):427-36. PubMed ID: 22187223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins.
    Hu Y; Cheng X; Li S; Zhou Y; Wang J; Cheng T; Yang M; Xiong D
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):789-98. PubMed ID: 24013575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.
    Lombardo Y; Faronato M; Filipovic A; Vircillo V; Magnani L; Coombes RC
    Breast Cancer Res; 2014 Jun; 16(3):R62. PubMed ID: 24919951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALDH1 expression correlates with an epithelial-like phenotype and favorable prognosis in lung adenocarcinoma: a study based on immunohistochemistry and mRNA expression data.
    Koh YW; Han JH; Haam S; Jung J
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1427-1436. PubMed ID: 30923946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
    Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
    Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
    Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatinized protein kinase C-θ directly regulates inducible genes in epithelial to mesenchymal transition and breast cancer stem cells.
    Zafar A; Wu F; Hardy K; Li J; Tu WJ; McCuaig R; Harris J; Khanna KK; Attema J; Gregory PA; Goodall GJ; Harrington K; Dahlstrom JE; Boulding T; Madden R; Tan A; Milburn PJ; Rao S
    Mol Cell Biol; 2014 Aug; 34(16):2961-80. PubMed ID: 24891615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells.
    Park SY; Kim MJ; Park SA; Kim JS; Min KN; Kim DK; Lim W; Nam JS; Sheen YY
    Oncotarget; 2015 Nov; 6(35):37526-43. PubMed ID: 26462028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
    Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB
    Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
    Alberti L; Losi L; Leyvraz S; Benhattar J
    PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines.
    Xu P; Jiang YF; Wang JH
    Int J Clin Exp Pathol; 2015; 8(3):2300-10. PubMed ID: 26045737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.
    Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y
    Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCG2 is a potential marker of tumor-initiating cells in breast cancer.
    Sicchieri RD; da Silveira WA; Mandarano LR; de Oliveira TM; Carrara HH; Muglia VF; de Andrade JM; Tiezzi DG
    Tumour Biol; 2015 Dec; 36(12):9233-43. PubMed ID: 26091795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway.
    Pan Y; Chen J; Tao L; Zhang K; Wang R; Chu X; Chen L
    Oncotarget; 2017 May; 8(20):33144-33158. PubMed ID: 28388536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
    Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
    Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversing effect and mechanism of soluble resistance-related calcium-binding protein on multidrug resistance in human lung cancer A549/DDP cells.
    Gao Y; Li W; Liu X; Gao F; Zhao X
    Mol Med Rep; 2015 Mar; 11(3):2118-24. PubMed ID: 25394367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
    Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
    Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα(+) breast cancer cells.
    D'Assoro AB; Liu T; Quatraro C; Amato A; Opyrchal M; Leontovich A; Ikeda Y; Ohmine S; Lingle W; Suman V; Ecsedy J; Iankov I; Di Leonardo A; Ayers-Inglers J; Degnim A; Billadeau D; McCubrey J; Ingle J; Salisbury JL; Galanis E
    Oncogene; 2014 Jan; 33(5):599-610. PubMed ID: 23334326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.